MAP3K7 (Phospho-Thr187) Antibody
- Known as:
- MAP3K7 (Phospho-Thr187) Antibody
- Catalog number:
- 11899
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Signalway
- Gene target:
- MAP3K7 (Phospho-Thr187) Antibody
Related genes to: MAP3K7 (Phospho-Thr187) Antibody
- Gene:
- MAP3K7 NIH gene
- Name:
- mitogen-activated protein kinase kinase kinase 7
- Previous symbol:
- TAK1
- Synonyms:
- MEKK7
- Chromosome:
- 6q15
- Locus Type:
- gene with protein product
- Date approved:
- 1998-05-22
- Date modifiied:
- 2016-04-20
- Gene:
- TAB1 NIH gene
- Name:
- TGF-beta activated kinase 1 (MAP3K7) binding protein 1
- Previous symbol:
- MAP3K7IP1
- Synonyms:
- -
- Chromosome:
- 22q13.1
- Locus Type:
- gene with protein product
- Date approved:
- 2002-02-22
- Date modifiied:
- 2016-07-20
- Gene:
- TAB2 NIH gene
- Name:
- TGF-beta activated kinase 1 (MAP3K7) binding protein 2
- Previous symbol:
- MAP3K7IP2
- Synonyms:
- KIAA0733
- Chromosome:
- 6q25.1
- Locus Type:
- gene with protein product
- Date approved:
- 2002-02-22
- Date modifiied:
- 2018-02-12
- Gene:
- TAB3 NIH gene
- Name:
- TGF-beta activated kinase 1 (MAP3K7) binding protein 3
- Previous symbol:
- MAP3K7IP3
- Synonyms:
- -
- Chromosome:
- Xp21.2
- Locus Type:
- gene with protein product
- Date approved:
- 2006-06-26
- Date modifiied:
- 2018-02-12
Related products to: MAP3K7 (Phospho-Thr187) Antibody
Related articles to: MAP3K7 (Phospho-Thr187) Antibody
- TGF-β-activated kinase 1 (TAK1 or MAP3K7) is an intracellular hub molecule that regulates both nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways that play key roles in development, cell survival, immune response, metabolism, and carcinogenesis. TAK1 activity is tightly regulated by its binding proteins, TAB1 and TAB2/TAB3, as well as by post-translational modification including ubiquitination and phosphorylation. Accumulating evidence demonstrates that TAK1 plays a role in tumor initiation, progression, and metastasis as a tumor prompter or tumor suppressor. An understanding of the role of TAK1 in liver physiology and diseases is required for the development of therapeutic agencies targeting TAK1. In this review, we highlight the activation mechanism and pathophysiological roles of TAK1 in the liver. - Source: PubMed
Publication date: 2014/01/21
Roh Yoon SeokSong JingyiSeki Ekihiro